Bioscience Vaccines grabs 400k in seed funding, begins preparation for clinical trials
Bioscience Vaccines Inc. has received a $400,000 seed investment to develop technology that enhances the effectiveness of vaccines. Bioscience Vaccines will use the funding to prepare for a Phase 1 human clinical trial. The company no doubt hopes that recent publicity surrounding vaccines for H1N1 will help it draw attention from additional investors. The funding […]